Blueberry Extract Boosts Cancer Treatment Efficacy, Therapeutic Solutions Says
Therapeutic Solutions says animal study data show synergy in use of NanoStilbene, its proprietary formulation of pterostilbene, together with anti-CTLA4 antibody, "the mouse equivalent" of ipilimumab, an immunotherapeutic in the "checkpoint inhibitors" family of drugs. It also notes early results of clinical trial with cancer patients suggesting NanoStilbene efficacy in increased activity of immune system "natural killer" cells and enhanced production of interferon gamma, a protein associated with cancer growth suppression.
You may also be interested in...
As in previous warnings to kratom supplement marketers linked to opioid addiction treatment claims, FDA tells Cali Botanicals and Kratom NC that HHS in 2017 found opioid abuse was nationwide public health emergency and FDA is targeting products that without approval claim to diagnose, mitigate, prevent, treat or cure opioid addiction. Contract manufacturer Somlabs' GMP problems also were identified in FDA's latest warning letters.
FTC joins FDA in one of the three warning letters to firms claiming their products can either prevent or treat Ebola.